Printed From:

Lantus (insulin glargine [rDNA origin] injection) SoloStar Pen

A BASAL INSULIN WITH DATA THAT SHOW1,2:

Including CV death, nonfatal MI, nonfatal stroke, revascularization, or hospitalization for heart failure. No difference was observed between Lantus® and standard of care in overall incidence of CV death, non-fatal MI, or non-fatal stroke. No difference was observed between treatment groups for death of any cause.

Proven HbA1c control

Once-daily dosing

Demonstrated long-term CV safety

References:

  1. Lantus® Prescribing Information.
    February 2015.
  2. Data on file, Sanofi U.S. LLC.